* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download FOR IMMEDIATE RELEASE CONTACT: Name Institution Telephone
Neurolinguistics wikipedia , lookup
Embodied cognitive science wikipedia , lookup
Blood–brain barrier wikipedia , lookup
Metastability in the brain wikipedia , lookup
Neurophilosophy wikipedia , lookup
Neuroanatomy wikipedia , lookup
Persistent vegetative state wikipedia , lookup
Brain morphometry wikipedia , lookup
Dual consciousness wikipedia , lookup
Neuropsychology wikipedia , lookup
Visual selective attention in dementia wikipedia , lookup
Neuropsychopharmacology wikipedia , lookup
Aging brain wikipedia , lookup
Cognitive neuroscience wikipedia , lookup
Haemodynamic response wikipedia , lookup
Impact of health on intelligence wikipedia , lookup
Positron emission tomography wikipedia , lookup
Clinical neurochemistry wikipedia , lookup
Alzheimer's disease wikipedia , lookup
FOR IMMEDIATE RELEASE CONTACT: Name Institution Telephone e-mail [Name of Center] now offers a new imaging tool to visualize evidence of amyloid plaques when evaluating for Alzheimer’s disease or other causes of cognitive decline: the Biograph mCT PET•CT scanner from Siemens. [CITY, STATE, DATE] ― Physicians at [Facility Name] can now offer advanced noninvasive brain imaging that can detect amyloid plaques, a sign of Alzheimer's disease, in the living brain. This new noninvasive approach uses a unique radiopharmaceutical imaging agent in combination with Siemens' Biograph mCT PET•CT family of scanners and proprietary neurology quantification software.* The radiopharmaceutical helps physicians visualize protein deposits in the brain called amyloid plaques. In a healthy brain, these deposits are broken down and eliminated. In patients with Alzheimer’s disease, the deposits accumulate over time to form hard plaques that build up between cells in the brain. Although there is currently no cure for Alzheimer's, if it is evaluated early in the disease process patients and their physicians can have additional time to explore treatment options and prepare for the future. [Suggested Physician Quote] “We are excited about the new capabilities the Biograph mCT scanner brings to [Facility Name],” said [Physician name, title]. “The number of people living with Alzheimer's has the potential to increase substantially over the next fifty years, so continuing research into its evaluation and new treatments is critical.” Biograph mCT, while providing accurate and reproducible quantification in PET•CT imaging, also offers exceptional comfort for patients up to 500 lb. With a large, patient-friendly 78-cm bore opening, its open design and fast scan times help to enhance patient comfort and may make patients feel less claustrophobic. Additionally, Biograph mCT uses multiple innovative dose-reducing technologies to minimize patient exposure to radiation, and the system's fast scan times result in less patient motion, so image quality can be optimized. Suggested physician quote to wrap up release “The Siemens Biograph mCT gives [Facility Name] one of the most cuttingedge imaging systems available today,” said [Dr .Name.] “Siemens’ Biograph mCT sets a new standard in diagnostic imaging for dementia and other causes of cognitive decline. This system can significantly impact clinical outcomes for our neurology patients by providing answers throughout the disease process.” Insert Facility Boiler Plate Press Contact Name, Title Phone, E-mail * syngo(R).PET Amyloid Plaque is intended for use only with approved amyloid radiopharmaceuticals in the country of use. Users should review the drug labeling for approved uses ###